102 related articles for article (PubMed ID: 27606940)
1. Acetyl-L-carnitine undervalued in the treatment of chemotherapy-induced peripheral neuropathy?
van Dam DG; Beijers AJ; Vreugdenhil G
Acta Oncol; 2016 Dec; 55(12):1495-1497. PubMed ID: 27606940
[No Abstract] [Full Text] [Related]
2. Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?
Burotto M; Fojo AT
Oncologist; 2013; 18(11):1151-2. PubMed ID: 24217999
[No Abstract] [Full Text] [Related]
3. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.
Flatters SJ; Xiao WH; Bennett GJ
Neurosci Lett; 2006 Apr; 397(3):219-23. PubMed ID: 16406309
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
De Grandis D
CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced peripheral neuropathy #197.
Fernandez C; Mehta Z; Espenlaub A; Ellison N
J Palliat Med; 2014 Aug; 17(8):965-6. PubMed ID: 25026539
[No Abstract] [Full Text] [Related]
6. Editorial: Supplements and Chemotherapy-Induced Peripheral Neuropathy: Hope or Hype?
Ligibel JA
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 30053079
[No Abstract] [Full Text] [Related]
7. A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
Campone M; Berton-Rigaud D; Joly-Lobbedez F; Baurain JF; Rolland F; Stenzl A; Fabbro M; van Dijk M; Pinkert J; Schmelter T; de Bont N; Pautier P
Oncologist; 2013; 18(11):1190-1. PubMed ID: 24105751
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy.
Maestri A; De Pasquale Ceratti A; Cundari S; Zanna C; Cortesi E; Crinò L
Tumori; 2005; 91(2):135-8. PubMed ID: 15948540
[TBL] [Abstract][Full Text] [Related]
9. Prevention of chemotherapy-induced neuropathy: leukemia inhibitory factor.
van den Bent MJ
Clin Cancer Res; 2005 Mar; 11(5):1691-3. PubMed ID: 15755989
[No Abstract] [Full Text] [Related]
10. Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study.
Osio M; Muscia F; Zampini L; Nascimbene C; Mailland E; Cargnel A; Mariani C
J Peripher Nerv Syst; 2006 Mar; 11(1):72-6. PubMed ID: 16519785
[TBL] [Abstract][Full Text] [Related]
11. What's L-A-C got to do with it?
Notes Undergr; 1997 Nov; (No 36):6. PubMed ID: 11365206
[TBL] [Abstract][Full Text] [Related]
12. Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery.
Storey DJ; Colvin LA; Mackean MJ; Mitchell R; Fleetwood-Walker SM; Fallon MT
J Pain Symptom Manage; 2010 Jun; 39(6):e2-4. PubMed ID: 20538177
[No Abstract] [Full Text] [Related]
13. Drug-related neuropathy: low acetylcarnitine levels found.
James JS
AIDS Treat News; 1997 Feb; (No 265):6-7. PubMed ID: 11364244
[TBL] [Abstract][Full Text] [Related]
14. Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol.
Binienda ZK; Beaudoin MA; Gough B; Ali SF; Virmani A
Neurosci Lett; 2010 Aug; 480(2):117-21. PubMed ID: 20542088
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency.
Schloss JM; Colosimo M; Airey C; Vitetta L
Support Care Cancer; 2015 Jul; 23(7):1843-50. PubMed ID: 25863665
[No Abstract] [Full Text] [Related]
16. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients.
Scarpini E; Sacilotto G; Baron P; Cusini M; Scarlato G
J Peripher Nerv Syst; 1997; 2(3):250-2. PubMed ID: 10975731
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced peripheral neuropathy in pediatric cancer patients.
Gilchrist L
Semin Pediatr Neurol; 2012 Mar; 19(1):9-17. PubMed ID: 22641071
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.
Ghirardi O; Lo Giudice P; Pisano C; Vertechy M; Bellucci A; Vesci L; Cundari S; Miloso M; Rigamonti LM; Nicolini G; Zanna C; Carminati P
Anticancer Res; 2005; 25(4):2681-7. PubMed ID: 16080512
[TBL] [Abstract][Full Text] [Related]
19. Treatment with acetyl-L-carnitine has the potential to improve the clinical course of painful peripheral neuropathies in HIV-positives patients.
Famularo G; De Simone C
J Peripher Nerv Syst; 1998; 3(3):227-9. PubMed ID: 10959254
[No Abstract] [Full Text] [Related]
20. Symptoms: Chemotherapy-Induced Peripheral Neuropathy.
Schneider BP; Hershman DL; Loprinzi C
Adv Exp Med Biol; 2015; 862():77-87. PubMed ID: 26059930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
